surmount-1 tirzepatide trial weight loss results Reduction of prevalence of patients meeting the criteria for Tirzepatide after intensive lifestyle intervention

Glia 61, 869880

6 Patients need information regarding the progressive nature of diabetes, factors that can control diabetes, current glycemic control status, current or potential complications, how to prevent complications, and the importance of glycemic control

For male fertility , the evidence is especially strong

When stopped: Appetite often returns Weight regain is common Blood sugar control may worsen This reinforces the importance of long-term planning , not short-term use

Sometimes, the best way to confirm a drug reaction is a dechallenge and rechallenge

These drugs are cardioprotective in nondiabetic patients as well, with demonstrated decrease in plasma lipid levels and lower blood pressure